Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy

In recent years, knowledge on the biology and pathobiology of extracellular vesicles (EVs) has exploded. EVs are submicron membrane-bound structures secreted from different cell types containing a wide variety of bioactive molecules (e.g., proteins, lipids, and nucleic acids (coding and non-coding R...

Full description

Bibliographic Details
Main Authors:	Alejandra Hernández, Juan Pablo Arab, Daniela Reyes, Ainhoa Lapitz, Han Moshage, Jesús M. Bañales, Marco Arrese
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Cells
Subjects:	nonalcoholic fatty liver disease fatty liver alcoholic liver disease extracellular vesicles signaling exosomes
Online Access:	https://www.mdpi.com/2073-4409/9/4/817

Similar Items

Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
by: David Højland Ipsen, et al.
Published: (2021-01-01)

Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming
by: Xinming Su, et al.
Published: (2023-12-01)

A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study
by: Qiling Liu, et al.
Published: (2022-11-01)

The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
by: Zifeng Yang, et al.
Published: (2023-05-01)

The role of the microbiome in NAFLD and NASH
by: Aleksandra A Kolodziejczyk, et al.
Published: (2018-12-01)

Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells
by: Maria Teresa Koenen, et al.
Published: (2022-05-01)

Comparison of MAFLD and NAFLD Characteristics in Children
by: Yunfei Xing, et al.
Published: (2023-03-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications
by: Zongmei Wu, et al.
Published: (2022-07-01)

Multifocal fatty liver nodules mimicking a metastatic disease: A case report
by: Huy Quang Duong, et al.
Published: (2024-03-01)

Epidemiology and natural history of NAFLD
by: Della Corte Claudia, et al.
Published: (2015-01-01)

Lipotoxic hepatocyte derived LIMA1 enriched small extracellular vesicles promote hepatic stellate cells activation via inhibiting mitophagy
by: Shihui Li, et al.
Published: (2024-05-01)

Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
by: Chua, Damien, et al.
Published: (2023)

Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
by: Ankoor H. Patel, et al.
Published: (2024-07-01)

An Update on the Chemokine System in the Development of NAFLD
by: Naoto Nagata, et al.
Published: (2022-06-01)

NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
by: Renling Yao, et al.
Published: (2024-01-01)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
by: Jin Feng, et al.
Published: (2021-12-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
by: Hassan Pakravan, et al.
Published: (2017-01-01)

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
by: Yifei Chen, et al.
Published: (2022-10-01)

Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways
by: Glenn S. Gerhard, et al.
Published: (2018-07-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Noninvasive Diagnosis of NAFLD and NASH
by: Valeria Annarita Piazzolla, et al.
Published: (2020-04-01)

Prevalence and clinical characteristics of NAFLD in chronic liver disease patients from King Abdulaziz University Hospital, Jeddah
by: Hind Ibrahim Fallatah, et al.
Published: (2020-01-01)

TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD
by: Imke Liebold, et al.
Published: (2023-01-01)

Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
by: Pimsiri Sripongpun, et al.
Published: (2024-10-01)

Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus
by: Yu-Ming Cheng, et al.
Published: (2024-09-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease
by: Chanbin Lee, et al.
Published: (2022-04-01)

Global health burden of cirrhosis and other chronic liver diseases (CLDs) due to non-alcoholic fatty liver disease (NAFLD): A systematic analysis for the global burden of disease study 2019
by: Jie Li, et al.
Published: (2023-01-01)

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
by: Duck Min Seo, et al.
Published: (2023-04-01)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
by: Pyeong Hwa Kim, et al.
Published: (2022-10-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery
by: Marielle Malucelli, et al.
Published: (2023-11-01)

Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
by: Jesús Rivera-Esteban, et al.
Published: (2022-11-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

The effect of symbiotic supplementation on liver enzymes, c-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: A clinical trial
by: Atefe Asgharian, et al.
Published: (2016-01-01)

The effect of Ramadan fasting on non-alcoholic fatty liver disease (NAFLD) patients
by: Seyed Mostafa Arabi, et al.
Published: (2015-06-01)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
by: Yuna Kim, et al.
Published: (2022-03-01)